Key result
Pharmacologic inhibition of PI3K with LY294002 (20 μM) significantly decreased intracellular Ca2+ concentration from 132.6 nM to 117.1 nM and abolished Ca2+ transients in HL-1 cardiomyocytes.
Why the study?
Does pharmacologic inhibition of the PI3K/Akt pathway reduce intracellular calcium and calcium transients in murine HL-1 cardiomyocytes?
Does pharmacologic inhibition of the PI3K/Akt pathway reduce intracellular calcium and calcium transients in murine HL-1 cardiomyocytes?
Absolute Event Rate: 117.1% vs 132.6%
p-value: p=<0.003
The PI3K/Akt signaling pathway is essential for maintaining intracellular calcium levels and transients required for excitation-contraction coupling in cardiomyocytes.
PI3K inhibition may disrupt cardiomyocyte calcium handling; leaves open in vivo relevance and any clinical translation.
The phosphoinositide 3-kinases (PI3K/Akt) dependent signaling pathway plays an important role in cardiac function, specifically cardiac contractility. We have reported that sepsis decreases myocardial Akt activation, which correlates with cardiac dysfunction in sepsis. We also reported that preventing sepsis induced changes in myocardial Akt activation ameliorates cardiovascular dysfunction. In this study we investigated the role of PI3K/Akt on cardiomyocyte function by examining the role of PI3K/Akt-dependent signaling on [Ca(2+)](i), Ca(2+) transients and membrane Ca(2+) current, I(Ca), in cultured murine HL-1 cardiomyocytes. LY294002 (1-20 μM), a specific PI3K inhibitor, dramatically decreased HL-1 [Ca(2+)](i), Ca(2+) transients and I(Ca). We also examined the effect of PI3K isoform specific inhibitors, i.e. α (PI3-kinase α inhibitor 2; 2-8 nM); β (TGX-221; 100 nM) and γ (AS-252424; 100 nM), to determine the contribution of specific isoforms to HL-1 [Ca(2+)](i) regulation. Pharmacologic inhibition of each of the individual PI3K isoforms significantly decreased [Ca(2+)](i), and inhibited Ca(2+) transients. Triciribine (1-20 μM), which inhibits AKT downstream of the PI3K pathway, also inhibited [Ca(2+)](i), and Ca(2+) transients and I(Ca). We conclude that the PI3K/Akt pathway is required for normal maintenance of [Ca(2+)](i) in HL-1 cardiomyocytes. Thus, myocardial PI3K/Akt-PKB signaling sustains [Ca(2+)](i) required for excitation-contraction coupling in cardiomyoctyes.
No takes yet. Share an insight, caveat, or question.
Graves et al. (2012) studied Normal cardiomyocyte calcium regulation. PI3K and Akt inhibitors (e.g., LY294002, Triciribine) vs. Control (standard external salt solution) was evaluated on Intracellular Ca2+ concentration ([Ca2+]i) at 15 minutes (p=<0.003). Pharmacologic inhibition of PI3K with LY294002 (20 μM) significantly decreased intracellular Ca2+ concentration from 132.6 nM to 117.1 nM and abolished Ca2+ transients in HL-1 cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: